Skip to main content
OpenTrials
Completed

NCT Number: NCT02026765

Clinical Outcomes About Heparin Surface Modified Aspheric Lens

The purpose of this study is to obverse the effect of this type lens in the same as traditional aspheric intraocular lens at the same time, whether can further improve the effects of operation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Affiliated Eye hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325000, China

About this study

  • Heparin surface treatment lens can reduce inflammatory reaction.
  • Modified aspheric lens are more in line with human optical properties than the traditional aspheric lens.
  • To obverse the effect of this type lens in the same as traditional aspheric intraocular lens at the same time, whether can further improve the effects of operation.
  • After one day, one week, one month, three month follow-up,Key observation on the flare, the optical quality, contrast sensitivity and other parameters.Study the postoperative inflammatory reaction with test group lens,and the impact on the visual quality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cataract patients

Exclusion criteria

  • Eyed patients

Treatment and study plan

traditional lens

Device

A random eyes with traditional lens

heparin surface modified aspheric lens

Device

the other eye implant heparin surface modified aspheric lens

Primary outcomes

  1. flare value in the anterior chamber after surgery

    Time frame: six months

    use Laser Flare Meter to measure the flare in the anterior chamber to evaluate postoperative ocular inflammatory reaction

Secondary outcomes

  1. the ocular and the anterior corneal aberration after surgery

    Time frame: six months

    use wavefront aberrometer to measure the ocular and the anterior corneal aberration to evaluate postoperative ocular optical quality

Sponsors and collaborators

Lead sponsor

Wenzhou Medical University

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jan 3, 2014
Registry last updated
Dec 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.